About this episode
Host: Darryl S. Chutka, M.D.
Guest: Daniel M. Frendl, M.D., Ph.D.
If your practice includes middle age and older men, you’ve very likely diagnosed prostate cancer. It’s the most diagnosed non-skin cancer in men in the U.S. Its incidence rises with age, with a median age of around 66 years. When found early, prostate cancer is very treatable, and in most cases, curable. Prostate specific antigen, or PSA is very effective in detecting early prostate cancer, but its use has been controversial due to the risk of overdiagnosis and overtreatment. What are the current recommendations for prostate cancer screening with PSA? What’s the role of the digital rectal exam? How should we be using the PSA and what other tests are available for prostate cancer screening? The topic for this podcast is “Prostate Cancer Screening” and I’ll be asking these questions to my guest, Daniel M. Frendl, M.D., Ph.D., a urologist at the Arizona campus of the Mayo Clinic.
Tune in this Thursday for our next episode on "Prostate Cancer" releasing October 30, 2025.
Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts
Get every episode summarized
Each time Mayo Clinic Talks publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Mayo Clinic Talks
Advancements in the Diagnosis and Treatment of Parkinson’s Disease
Mayo Clinic Talks
Parkinson’s Disease in Children and Young Adults
Mayo Clinic Talks
Mayo Clinic Proceedings: Diabetes and Novel Therapies for Diabetes
Mayo Clinic Talks
Mayo Clinic Proceedings: Healthy Aging
Mayo Clinic Talks